Loading...
•
Mar 31, 2021
Twist Bioscience Q2 2021 Earnings Report
Reported revenue growth of 62% and order growth of 69% year over year, with a gross margin of 39%.
Key Takeaways
Twist Bioscience reported strong growth in all four areas of its business for the second quarter of fiscal year 2021. The company saw increasing revenue and strong orders, with new biopharma partnerships and progress in data storage density.
Revenue growth of 62% over fiscal year 2020 second quarter.
Order growth of 69% year over year.
Gross margin of 39% for the quarter.
Signed new biopharma partnerships with multiple associated programs.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...